Hyperbilirubinemia in infants with Gram-negative sepsis does not affect mortality

Area of Science:

• Neonatal Medicine
• Pediatric Infectious Diseases
• Biochemistry

Background:

• Sepsis involves increased oxidants and decreased antioxidants, leading to high mortality, especially with endotoxins in Gram-negative sepsis.
• Unconjugated hyperbilirubinemia has shown protective effects against endotoxin shock in animal models.
• This study investigated whether hyperbilirubinemia protects infants with Gram-negative sepsis.

Purpose of the Study:

• To examine the association between serum bilirubin levels and outcomes in infants with Gram-negative sepsis.
• To assess relationships between bilirubin, leukocyte count, C-reactive protein, and survival.
• To determine if bilirubin influences the inflammatory response in neonatal sepsis.

Main Methods:

• Retrospective analysis of clinical and biochemical data.
• Included infants under 90 days with blood culture-proven Gram-negative sepsis (1998-2005).
• Analyzed serum bilirubin, leukocyte count, and C-reactive protein in relation to survival.

Main Results:

• 92 infants with Gram-negative sepsis were identified; 22 died.
• Conjugated bilirubin increased, while unconjugated bilirubin decreased during sepsis.
• No significant difference in total bilirubin between survivors and non-survivors; no correlation with inflammatory markers.

Conclusions:

• The study's findings do not support a protective role for bilirubin in infant Gram-negative sepsis.
• Bilirubin levels did not significantly impact survival or inflammatory markers in this cohort.
• Further research may be needed to fully understand bilirubin's role in neonatal sepsis.